Evidence map›Paper›PMID 21666118›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2011

In vivo bioluminescence for tracking cell fate and function.

Patricia E de Almeida, Juliaan R M van Rappard, Joseph C Wu

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 115 citations in OpenAlex.

  1. Super-Resolution Ultrasound Based Cell Tracking With Polymeric Nanobubbles.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Introducing a new reporter gene, membrane-anchoredMolecular therapy oncolytics · 2021
    Article
  16. Article
  17. Article
  18. Molecular imaging in tracking cancer stem cells: A review.Medical journal of the Islamic Republic of Iran · 2020
    Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Patricia E de AlmeidaDepartment of Medicine, Stanford University School of Medicine, Stanford, California 94305-5454, USA.
Juliaan R M van Rappard
Joseph C Wu
California Institute for Regenerative Medicine · USLeiden University · NL

Funding

Molecular Imaging of Targeted Cardiac Gene TherapyR01HL093172 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2009 to 2015
$2.7M
Molecular Imaging of Cardiac Stem Cell TherapyR01EB009689 · NIBIB · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2010 to 2013
$1.4M
Molecular Imaging of Resident Cardiac Stem CellsRC1HL099117 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2009 to 2010
$1000k
NHLBI NIH HHS HL-093172NHLBI NIH HHS HL-099117NHLBI NIH HHS R01 HL093172NHLBI NIH HHS RC1 HL099117NIBIB NIH HHS EB-009689NIBIB NIH HHS R01 EB009689
6 · The paper itself

Abstract

Tracking the fate and function of cells in vivo is paramount for the development of rational therapies for cardiac injury. Bioluminescence imaging (BLI) provides a means for monitoring physiological processes in real time, ranging from cell survival to gene expression to complex molecular processes. In mice and rats, BLI provides unmatched sensitivity because of the absence of endogenous luciferase expression in mammalian cells and the low background luminescence emanating from animals. In the field of stem cell therapy, BLI provides an unprecedented means to monitor the biology of these cells in vivo, giving researchers a greater understanding of their survival, migration, immunogenicity, and potential tumorigenicity in a living animal. In addition to longitudinal monitoring of cell survival, BLI is a useful tool for semiquantitative measurements of gene expression in vivo, allowing a better optimization of drug and gene therapies. Overall, this technology not only enables rapid, reproducible, and quantitative monitoring of physiological processes in vivo but also can measure the influences of therapeutic interventions on the outcome of cardiac injuries.

Indexed as

Luminescent MeasurementsStem Cell TransplantationAnimalsCell DifferentiationCell MovementCells, CulturedCell SurvivalCell TrackingGene Expression RegulationGenes, ReporterHumansLuminescent ProteinsRecombinant Fusion ProteinsStem CellsTime FactorsTransfectionLuminescent ProteinsRecombinant Fusion Proteins

Identifiers

PMID21666118
PMCPMC3191083
OpenAlexW2146694099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.